
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.64 | 0.64 | 0.00 |
Shares | 97.03 | 97.03 | 0.00 |
Other | 2.33 | 2.50 | 0.17 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.13 | 19.18 |
Price to Book | 4.87 | 4.34 |
Price to Sales | 5.67 | 2.43 |
Price to Cash Flow | 17.75 | 16.74 |
Dividend Yield | 1.06 | 1.12 |
5 Years Earnings Growth | 7.69 | 12.19 |
Number of long holdings: 186
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 13.05 | 191.37 | +3.66% | |
Amgen | US0311621009 | 10.22 | 274.37 | +3.20% | |
Krystal Biotech | US5011471027 | 8.46 | 138.39 | +4.69% | |
Gilead | US3755581036 | 7.04 | 103.50 | +6.80% | |
Alnylam | US02043Q1076 | 4.68 | 265.46 | +5.70% | |
Vertex | US92532F1003 | 3.80 | 437.82 | +3.02% | |
Regeneron Pharma | US75886F1075 | 3.31 | 567.94 | +7.61% | |
Ascendis Pharma AS | US04351P1012 | 2.57 | 157.16 | +3.91% | |
argenx ADR | US04016X1019 | 2.54 | 560.13 | +1.91% | |
UCB | BE0003739530 | 2.34 | 158.35 | +2.59% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 593.97B | -4.92 | 12.17 | 12.31 | ||
Fidelity Contrafund | 133.44B | -3.29 | 18.13 | 14.54 | ||
Fidelity Total Market Index Instl b | 99.37B | -5.52 | 11.34 | 11.61 | ||
Fidelity International Index Inst | 58.83B | 12.35 | 10.69 | 5.65 | ||
Fidelity Blue Chip Growth | 54.71B | -12.53 | 16.00 | 16.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review